← Evidence map

ArticleTheranostics2026

Esterase-responsive albumin-binding PROTAC-mediated BRD4 degradation for cancer immunotherapy.

Hoyeon Lee et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.

1 paper cites it

2026
this papercites it
Full record →Abstract, authors, funding and every citing paper · PMID 42094600